| Literature DB >> 29324802 |
Zitong Huang1,2, Jingjing Huang1,2, Tianran Zhou1,2, Hongying Cao3, Bo Tan1,2.
Abstract
BACKGROUND: Previous studies have discussed the liver stiffness measurement (LSM) performance on predicting liver-related surgical outcomes for patients of hepatocellular carcinoma (HCC) under hepatic resection, yet there is much variation in reporting and consistency of findings. Therefore, we report a meta-analysis on this issue.Entities:
Mesh:
Year: 2018 PMID: 29324802 PMCID: PMC5764309 DOI: 10.1371/journal.pone.0190512
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1Flow diagram of the study selection process.
The fundamental features of the included studies.
| Study | Country | Case | Mean age | Gender | Time period | Etiology | Outcomes | LSM | NOS |
|---|---|---|---|---|---|---|---|---|---|
| Shen 2017[ | China | 280 | 56.1 | 240/40 | 2015–2016 | HBV, 100% | PHLF | SWE | 6 |
| Han 2017[ | China | 77 | 59 | 63/14 | 2014–2015 | HBV,89.6% | PHLF | SWE | 7 |
| Chong 2017[ | China | 255 | 58.6 | 218/37 | 2010–2014 | HBV,81.6% | PHLF | TE | 7 |
| Abe 2017[ | Japan | 175 | 69 | 123/52 | 2014–2016 | HBC,19.4% | complications | MRE | 8 |
| Nishio 2016[ | Japan | 177 | 68 | 140/37 | 2011–2014 | HBC,18.6% | PHLF | ARFI | 7 |
| Lee 2016 [ | China | 144 | 58.9 | 106/38 | 2010–2013 | HBV,80.5% | PHLF | MRE | 8 |
| Donadon 2016[ | Italy | 240 | 65 | 225/115 | 2012–2015 | HBV,2% | complications | TE | 6 |
| Cucchetti 2016[ | Italy | 202 | 64 | 171/31 | 2008–2014 | HBV,17.8% | PHLF | TE | 8 |
| Li 2015[ | China | 75 | 52.15 | 59/16 | 2012–2014 | HBV,100% | PHLF | TE | 7 |
| Wong 2013[ | China | 105 | 59 | 82/23 | 2010–2011 | HBV,66.7% | complications | TE | 8 |
| Harada 2012[ | Japan | 50 | 68 | 36/14 | 2009–2010 | HBV,10% | ascites | ARFI | 8 |
| Cescon 2012[ | Italy | 90 | 64 | 77/13 | 2008–2011 | HBV,17.8% | PHLF | TE | 8 |
| Kim 2008[ | Korea | 72 | 54.9 | 56/16 | 2006–2007 | HBV,83.3% | hepatic insufficiency | TE | 7 |
M/F, Male/female; LSM, liver stiffness measurement; PHLF, Post-hepatectomy Liver Failure; HBV, hepatitis B-virus; HCV, hepatitis C-virus; NOS, Newcastle–Ottawa Scale; TE, transient elastography; SWE, shear wave elastography; MRE, magnetic resonance elastography; ARFI, acoustic radio force impulse; ISGLS, International Study Group of Liver Surgery definition; EtOH, alcohol liver disease; NASH, non-alcoholic steatohepatitis; NBNC, non-hepatitis B and non-hepatitis C; NA, data not available.
Diagnostic data of each studies evaluating the performance of TE for postoperative complications.
| Study | LSM cut-off | Sensitivity (%) | Specificity (%) | BMI(Mean) | AUROC |
|---|---|---|---|---|---|
| Chong 2017 | 12 | 83 | 73 | 23.7 | 0.83 |
| Donadon 2016 | 9.7 | 88.9 | 67.3 | 25.1 | 0.728 |
| Li 2015 | 14.3 | 100 | 76.1 | NA | 0.915 |
| Wong 2013 | 12 | 85.7 | 71.8 | 23.2 | 0.79 |
| Cescon 2012 | 15.7 | 96.1 | 68.7 | 24.8 | 0.865 |
| Kim 2008 | 25.6 | 71.4 | 88.6 | 24.0 | 0.824 |
LSM, liver stiffness measurement; PHLF, Post-hepatectomy liver failure; BMI, body mass index; AUROC, area under the receiver operating characteristic curve; KPa, Kilopascal; NA, data not available.
Fig 2Forest plot on the associations between LSM and overall postoperative complications.
Fig 3Forest plot meta-analyses of studies evaluating the sensitivity of live stiffness measured by TE to predict the overall postoperative complications.
Fig 4Forest plot meta-analyses of studies evaluating the specificity of live stiffness measured by TE to predict the overall postoperative complications.
Fig 5SROC curves for 6 studies of live stiffness measured by TE to predict the overall postoperative complications.
Results of optimal LSM cut-off value using TE in predicting postoperative complications.
| Country | Studies | Patients(n) | Weighted Mean LSM value(KPa) | Range(KPa) |
|---|---|---|---|---|
| Asia countries | 4 | 507 | 14.2 | 12–25.6 |
| European countries | 2 | 330 | 11.3 | 9.7–15.7 |
| overall | 6 | 837 | 13.1 | 9.7–25.6 |
LSM, liver stiffness measurement; TE, transient elastography; KPa, Kilopascal.
Subgroup analyses for association between LSM and overall postoperative complications.
| Group factors | Subgroup | studies | Combined OR | 95%CI | Heterogeneity | |
|---|---|---|---|---|---|---|
| I2 | ||||||
| Regions | Asia | 10 | 2.30 | 1.75, 3.04 | 63.2% | 0.004 |
| Europe | 3 | 1.12 | 1.00, 1.26 | 78.5% | 0.010 | |
| Technique of LSM | MRE | 2 | 2.24 | 1.74, 2.89 | 0.0% | 0.536 |
| TE | 7 | 1.30 | 1.11,1.52 | 48.3% | 0.085 | |
| SWE | 2 | 1.98 | 1.16, 3.30 | 46.1% | 0.173 | |
| ARFI | 2 | 9.74 | 0.39, 240.25 | 76.2% | 0.040 | |
| Outcome | Composite complications | 3 | 2.87 | 1.65, 5.00 | 47.3% | 0.150 |
| PHLF | 7 | 1.46 | 1.23, 1.74 | 84.7% | 0.000 | |
| ascites | 2 | 7.70 | 0.17, 341.88 | 82.9% | 0.000 | |
| Hepatic insufficiency | 1 | 19.14 | 2.71, 135.27 | NA | NA | |
| Etiology of CLD | Mixed | 11 | 1.74 | 1.42, 2.13 | 87.0% | 0.000 |
| Viral hepatitis | 2 | 1.89 | 1.02, 3.49 | 62.0% | 0.105 | |
| Stage of fibrosis | The percentage of patients with fibrosis grade F4≥50% | 7 | 1.32 | 1.11, 1.57 | 80.4% | 0.000 |
| The percentage of patients with fibrosis grade F4<50% | 6 | 2.20 | 1.60, 3.01 | 64.2% | 0.016 |
LSM, liver stiffness measurement; TE, transient elastography; SWE, shear wave elastography; MRE, magnetic resonance elastography; ARFI, acoustic radio force impulse; CLD, chronic liver diseases.
Effect of individual studies on the pooled ORs of the prognostic value of liver stiffness measurement for overall postoperative complications.
| Study omitted | OR | LCI | HCI |
|---|---|---|---|
| Shen 2017 | 1.71 | 1.42 | 2.05 |
| Han 2017 | 1.77 | 1.46 | 2.14 |
| Chong 2017 | 1.73 | 1.44 | 2.09 |
| Abe 2017 | 1.67 | 1.39 | 2.00 |
| Nishio 2016 | 1.67 | 1.39 | 2.00 |
| Lee 2016 | 1.68 | 1.40 | 2.02 |
| Donadon 2016 | 1.72 | 1.43 | 2.07 |
| Cucchetti 2016 | 2.20 | 1.62 | 3.00 |
| Li 2015 | 1.80 | 1.48 | 2.20 |
| Wong 2013 | 1.71 | 1.42 | 2.04 |
| Harada 2012 | 1.72 | 1.44 | 2.06 |
| Cescon 2012 | 2.20 | 1.62 | 3.00 |
| Kim 2008 | 1.70 | 1.43 | 2.04 |